Since 1996, BizInt Smart Charts software has helped analysts create reports and visualizations from drug pipeline, clinical trial, patents and IP sequence data.
Seattle, WA
Joined June 2017
- Tweets125
- Following16
- Followers37
- Likes103
Join us tomorrow for a free webinar (presented by SLA DPHT) as Matt and Diane share technical details and lessons learned from our COVID-19 vaccine landscape.
Register at attendee.gotowebinar.com/reg…
We've been burning the midnight oil the last two weeks, but Version 5.3 of the BizInt Smart Charts Drug Development Suite is ready, introducing support for GlobalData.
Learn more at bizint.com/drugs
We've been so busy getting the next release of the Drug Development Suite ready that we forgot to tweet this week's update!
Lots of activity in the COVID vaccine landscape - see all the details at bizint.com/covid including geographic details in a piano chart
Drug pipeline databases have a lot more structured detail which allows us to slice and dice the COVID-19 vaccine landscape. Here are vaccines not in development in the US, UK, and Europe. See bizint.com/COVID for more
This update of our COVID-19 Vaccine Landscape is a reset of the process. We are now using commercial drug pipelines data rather than public trial registry data - we will be refining the presentation over the coming weeks.
bizint.com/covid
Our latest COVID-19 vaccine landscape doesn't show a lot of change from the last update. However we expect to see quite a bit of activity in the coming weeks.
bizint.com/covid
The first 2021 update of our COVID-19 Vaccine development landscape is now available at bizint.com/COVID
Our final COVID-19 vaccine landscape of 2020, showing Moderna's vaccine joining BioNTech/Pfizer with authorizations. Still a lot of work being done - see the whole picture at bizint.com/COVID
The pace of development of a COVID-19 vaccine has been incredible. This summer we shared our first bullseye and with this update the first vaccine has been issued an EUA.
See the other vaccines on the horizon at bizint.com/covid
The type of news that sadly stretches the timeline for 2021. In an explanatory timeline, how do we represent this? Stretch the bar for the trial? Move milestones?
There has been some great news on #Covid19 vaccine trials but this kind of ends that streak. Sanofi runs into a problem that sets back one of the world’s largest vaccine producers — and every country that hoped to buy from them. statnews.com/2020/12/11/sano…
The latest update of our COVID-19 vaccine bullseye is up. Here we zoom in on technology areas with a lot of activity, but there are changes all over the landscape including several more vaccines starting Phase 3 trials.
See the complete picture at bizint.com/covid
The latest update to our COVID-19 vaccine bullseye is available at bizint.com/covid, including the first live-attenuated vaccine.
A new glyph highlights programs (currently BioNTech/Pfizer and Moderna) reporting Phase 3 efficacy data.
New vaccines for COVID-19 continue to register trials at clinicaltrials.gov, as shown on the latest update of our COVID-19 Vaccine Bullseye. Learn more at bizint.com/covid
